Magrabi Eye and Ear Center, Dammam, Saudi Arabia.
Ophthalmology. 2011 Apr;118(4):636-41. doi: 10.1016/j.ophtha.2010.08.038. Epub 2010 Nov 4.
To evaluate the effects of intervals between preoperative intravitreal injection of bevacizumab (IVB) and surgery on the components of removed diabetic fibrovascular proliferative membranes.
Interventional, consecutive, prospective, comparative case series.
A total of 52 eyes of 49 patients with active diabetic fibrovascular proliferation with complications necessitating vitrectomy.
Participant eyes that had IVB were divided into 8 groups in which vitreoretinal surgery was performed at days 1, 3, 5, 7, 10, 15, 20, and 30 postinjection. A group of eyes with the same diagnosis and surgical intervention without IVB injection was used for comparison. In all eyes, proliferative membrane specimens obtained during vitrectomy were sent for histopathologic examination using hematoxylin-eosin stain, immunohistochemistry (CD34 and smooth muscle actin), and Masson's trichrome stain.
Comparative analysis of different components of the fibrovascular proliferation (CD34, smooth muscle actin, and collagen) among the study groups.
Pan-endothelial marker CD34 expression levels starting from day 5 postinjection were significantly less than in the control group (P < 0.001), with minimum expression (1+) in all specimens removed at or after day 30 postinjection. Positive staining for smooth muscle actin was barely detected in the control eyes at day 1, and consistently intense at day 15 and beyond (P < 0.001). The expression level of trichrome staining was significantly high at day 10, compared with control eyes (P < 0.001), and continued to increase at subsequent surgical time points.
A profibrotic switch was observed in diabetic fibrovascular proliferation after IVB, and our results suggest that at approximately 10 days post-IVB the vascular component of proliferation is markedly reduced, whereas the contractile components (smooth muscle actin and collagen) are not yet abundant.
评估术前玻璃体内注射贝伐单抗(IVB)与手术之间的间隔时间对糖尿病性纤维血管性增殖膜切除成分的影响。
介入、连续、前瞻性、对照病例系列研究。
52 只眼,共 49 例糖尿病性纤维血管性增殖伴有并发症,需要玻璃体切除术的患者。
将接受 IVB 的参与者的眼睛分为 8 组,在注射后第 1、3、5、7、10、15、20 和 30 天行玻璃体视网膜手术。一组具有相同诊断和手术干预但不注射 IVB 的眼睛用于比较。在所有眼中,在玻璃体切除术中获得的增生性膜标本均进行苏木精-伊红染色、免疫组织化学(CD34 和平滑肌肌动蛋白)和 Masson 三色染色的组织病理学检查。
比较研究组中纤维血管增殖的不同成分(CD34、平滑肌肌动蛋白和胶原)。
从注射后第 5 天开始,泛内皮标志物 CD34 的表达水平明显低于对照组(P<0.001),所有在注射后第 30 天或之后切除的标本均表现出最小表达(1+)。在对照组中,平滑肌肌动蛋白的阳性染色在第 1 天几乎检测不到,在第 15 天及以后一直强烈(P<0.001)。与对照组相比,第 10 天三原色染色的表达水平显著升高(P<0.001),并在随后的手术时间点持续增加。
在 IVB 后,糖尿病性纤维血管性增殖中观察到促纤维化转变,我们的结果表明,大约在 IVB 后 10 天,增殖的血管成分明显减少,而收缩成分(平滑肌肌动蛋白和胶原)尚未丰富。